PNPLA4 anticorps (AA 1-103) (FITC)
Aperçu rapide pour PNPLA4 anticorps (AA 1-103) (FITC) (ABIN7153383)
Antigène
Voir toutes PNPLA4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-103
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human G0/G1 switch protein 2 protein (1-103AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PNPLA4 (Patatin-Like phospholipase Domain Containing 4 (PNPLA4))
-
Autre désignation
- GS2
-
Sujet
-
Background: Promotes apoptosis by binding to BCL2, hence preventing the formation of protective BCL2-BAX heterodimers.
Aliases: G0/G1 switch regulatory protein 2 antibody, G0/G1switch 2 antibody, G0s2 antibody, G0S2_HUMAN antibody, OTTHUMP00000034644 antibody, Putative lymphocyte G0/G1 switch protein 2 antibody, RP1 28O10.2 antibody
-
UniProt
- P27469
Antigène
-